(Delayed Data from OTC)
$0.00 USD
0.00
500,000
0.00 (0.00%)
Updated Jul 24, 2024 10:49 AM ET
Zacks Rank:
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.03% |
| 2 | Buy | 17.70% |
| 3 | Hold | 9.37% |
| 4 | Sell | 5.03% |
| 5 | Strong Sell | 2.48% |
| S&P | 500 | 11.19% |
Zacks Rank Education - Learn about the Zacks Rank
Zacks Rank Home - Zacks Rank resources in one place
Zacks Premium - The only way to fully access the Zacks Rank
Style Scores:
The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.
| Value Score | A |
|---|---|
| Growth Score | A |
| Momentum Score | A |
| VGM Score | A |
Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.
As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.
Zacks Style Scores Education - Learn more about the Zacks Style Scores
NAValue | NAGrowth | NAMomentum | NAVGM
Industry Rank:
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
Top 35% (89 out of 251)
Industry: Medical Info Systems
View All Zacks #1 Ranked Stocks
Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers. The Company's solutions include diagnostic solutions, revenue cycle management, healthcare software solutions, financial services, diagnostic laboratory testing and analytics for precision medicine, electronic health records and other software services. Rennova Health, Inc., formerly known as CollabRx, Inc., is headquartered in West Palm Beach, Florida.
Rennova Health, Inc
400 S. Australian Avenue Suite 800
West Palm Beach, FL 33401
Phone: 561-855-1626
Fax: 415-248-5351
Web: http://www.rennovahealth.com
Email: investors@collabrx.com
| Industry | Medical Info Systems |
| Sector | Medical |
| Fiscal Year End | December |
| Last Reported Quarter | 6/30/2024 |
| Exp Earnings Date This is an estimated date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information. | NA |
| Current Quarter EPS Consensus Estimate | NA |
| Current Year EPS Consensus Estimate | NA |
| Estimated Long-Term EPS Growth Rate | NA |
| Exp Earnings Date This is an estimated date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information. | NA |
| Zacks Rank | |
| Yesterday's Close | 0.00 |
| 52 Week High | 0.00 |
| 52 Week Low | 0.00 |
| Beta | 14.70 |
| 20 Day Moving Average | 44,113,212.00 |
| Target Price Consensus | 0.00 |
| 4 Week | 0.00 |
| 12 Week | 0.00 |
| YTD | NA |
| 4 Week | 0.03 |
| 12 Week | -6.07 |
| YTD | NA |
| Shares Outstanding (millions) | 40,551.32 |
| Market Capitalization (millions) | 4.06 |
| Short Ratio | NA |
| Last Split Date | 8/3/2020 |
| Dividend Yield | 0.00% |
| Annual Dividend | $0.00 |
| Payout Ratio | NA |
| Change in Payout Ratio | NA |
| Last Dividend Payout / Amount | NA / $0.00 |
| P/E (F1) | NA |
| Trailing 12 Months | NA |
| PEG Ratio | NA |
| vs. Previous Year | NA |
| vs. Previous Quarter | NA |
| vs. Previous Year | 25.19% |
| vs. Previous Quarter | -44.62% |
| Price/Book | NA |
| Price/Cash Flow | NA |
| Price / Sales | 0.20 |
| 6/30/24 | NA |
| 3/31/24 | NA |
| 12/31/23 | NA |
| 6/30/24 | NA |
| 3/31/24 | NA |
| 12/31/23 | NA |
| 6/30/24 | NA |
| 3/31/24 | NA |
| 12/31/23 | NA |
| 6/30/24 | NA |
| 3/31/24 | NA |
| 12/31/23 | NA |
| 6/30/24 | NA |
| 3/31/24 | NA |
| 12/31/23 | NA |
| 6/30/24 | NA |
| 3/31/24 | NA |
| 12/31/23 | NA |
| 6/30/24 | NA |
| 3/31/24 | NA |
| 12/31/23 | NA |
| 6/30/24 | NA |
| 3/31/24 | NA |
| 12/31/23 | NA |
| 6/30/24 | NA |
| 3/31/24 | NA |
| 12/31/23 | NA |
| 6/30/24 | NA |
| 3/31/24 | NA |
| 12/31/23 | NA |
| 6/30/24 | NA |
| 3/31/24 | NA |
| 12/31/23 | NA |
